Also, because we pass on more than 99% of the negotiated rebates from Novo directly to these employers, they can use these savings to lower member premiums, lower member copays, and/or broaden access and choice. The company said consumers will soon be able to purchase Wegovy at 9,000 CVS pharmacies for $499 more than half off the list price they previously would have needed to pay at a community pharmacy for either Wegovy or Zepbound
Yesil S, Sungu N, Kilicarslan A, Kuskonmaz SM, Kara H, Kucuk A, et al
Delayed Gastric Emptying: GLP-1 also decelerates the emptying of the stomach, prolonging food retention in the digestive system
#Pharma #GLP1 #ObesityTreatment #DrugDevelopment #HealthcareInnovation #EliLilly #NovoNordisk #PharmaceuticalIndustry To view or add a comment, sign in NEW DRUG APPROVAL ALERT The FDA has approved Foundayo (orforglipron), a new once-daily oral GLP-1 for chronic weight management in adults with obesity, or adults with overweight plus at least one weight-related condition
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery